SCARLETRED is proud to be the Lead Partner of the 10^th anniversary of the Dermatology Drug Development Summit in Boston, Massachusetts. The Summit is the industry’s premier forum dedicated to advancing the discovery, development, and commercialization of innovative therapies for inflammatory skin disease.

Bringing together over 100 leaders from the industry’s most prestigious key players, this year's expanded program explores the future of dermatology innovation across a wide range of dermatological conditions, including Atopic Dermatitis, Psoriasis, Hidradenitis Suppurativa, Vitiligo, Alopecia Areata, Acne, Epidermolysis Bullosa, and more.  

SCARLETRED is proud to be the continuous Lead Partner of the Summit. Attendees will gain actionable insights into AI-enabled, digital skin clinimetry and endpoints of skin drug-related effects.  

SCARLETRED will present its latest findings on AI-powered skin imaging, analysis, and disease severity scoring, all built on the CE-certified Software as a Medical Device (SaMD) Scarletred®Vision, a Skin Intelligence Platform powered by ARORA®AI.

Save the date: 10^th DDD US Summit 2026

• November 3-5, 2026

• Boston, Massachusetts

• More information here: https://dermatology-drugdevelopment.com/  

Stay tuned for Dr. Harald Schnidar's panel on Scarletred®Vision - the Skin Intelligence Platform for digital skin clinimetry and endpoints.

Download the agenda here: https://dermatology-drugdevelopment.com/day-one/

‍